Elder Pharmaceuticals Ltd. - Research Center
532322 ELDERPHARM Group (Z) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Dec ' 14 |
Dec ' 13 |
Mar ' 13 |
Sep ' 12 |
Mar ' 12 |
Sales |
119.71 |
291.00 |
481.31 |
562.54 |
501.24 |
Operating profit |
-57.22 |
67.28 |
94.61 |
116.57 |
102.71 |
Interest |
55.75 |
76.44 |
47.15 |
47.17 |
41.60 |
Gross profit |
-104.09 |
-1.71 |
61.87 |
81.17 |
65.65 |
EPS (Rs) |
-58.39 |
-8.07 |
18.46 |
23.79 |
19.40 |
Half yearly
results in details
|
Dec ' 14 |
Dec ' 13 |
Mar ' 13 |
Sep ' 12 |
Mar ' 12 |
Other income |
8.88 |
7.45 |
14.40 |
11.78 |
4.53 |
Stock adjustment |
3.60 |
25.42 |
-40.54 |
64.97 |
-20.68 |
Raw material |
20.32 |
26.46 |
41.86 |
67.73 |
44.07 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
31.48 |
51.93 |
62.40 |
63.69 |
60.42 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
121.53 |
119.91 |
322.98 |
249.58 |
314.72 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
15.82 |
14.86 |
14.21 |
14.97 |
12.28 |
Taxation |
- |
- |
9.75 |
12.25 |
10.09 |
Net profit / loss |
-119.91 |
-16.57 |
37.91 |
48.86 |
39.83 |
Extra ordinary item |
- |
- |
- |
-5.09 |
-3.44 |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
20.54 |
20.54 |
20.54 |
20.54 |
20.54 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
151.98 |
123.24 |
123.44 |
124.05 |
Agg.of non promotoholding (%) |
- |
74.00 |
60.01 |
60.10 |
60.40 |
OPM (%) |
-47.80 |
23.12 |
19.66 |
20.72 |
20.49 |
GPM (%) |
-80.95 |
-.57 |
12.48 |
14.13 |
12.98 |
NPM (%) |
-93.25 |
-5.55 |
7.65 |
8.51 |
7.88 |